静脉血栓症中的生物标志物:诊断潜力和限制
Yijin Chang1, Jiahao Lu1, Changsheng Chen1
1Nantong Laboratory of Development and Diseases, School of Life Sciences, Nantong University, Nantong 226019, China.
Biology
|July 29, 2025
概括
为静脉血栓栓塞 (VTE) 开发敏感的生物标志物,包括深静脉血栓塞 (DVT) 和肺栓塞 (PE),对于早期检测和改善患者的治疗结果至关重要. 本综述探讨了目前和未来对VTE诊断的生物标志物研究.
科学领域:
- 血管医学 血管医学
- 生物标志物发现发现
- 诊断技术 诊断技术 诊断技术
背景情况:
- 静脉血栓塞栓症 (VTE),包括深静脉血栓症 (DVT) 和肺栓塞 (PE),代表了严重的血管疾病,具有相当大的发病率和死亡率.
- 目前用于VTE的诊断方法,包括超声波,CTA和MRI,通常资源密集,耗时,并带有辐射暴露等风险.
- 迫切需要改进诊断工具,需要开发高度敏感和特定的生物标志物,以便早期检测VTE.
研究的目的:
- 审查静脉血栓症的既定和新兴生物标志物.
- 评估VTE生物标志物研究当前的挑战.
- 概述新的VTE生物标志物开发的有希望的未来方向.
主要方法:
- 对VTE的现有和新生物标志物的综合文献综述.
- 分析当前的诊断成像模式及其局限性.
- 评估VTE生物标志物发现的研究趋势和未来前景.
主要成果:
- 已建立的生物标志物显示出希望,但需要进一步验证才能广泛临床使用.
- 新兴的生物标志物显示出在VTE检测中提高灵敏度和特异性的潜力.
- 在将生物标志物研究转化为VTE诊断的常规临床实践方面,仍然存在重大挑战.
结论:
- 基于生物标志物的诊断为改善VTE的早期和准确检测提供了一个有希望的途径.
- 克服当前的研究和临床实施挑战对于实现VTE生物标志物的全部潜力至关重要.
- 未来的研究应该专注于开发可靠的,经过验证的生物标志物,以补充或取代用于VTE管理的现有成像技术.
相关概念视频
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
37
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
37
01:30Venous Thrombosis I: Introduction
41
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
41
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:30Venous Thrombosis IV: Nursing Management
24
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
24
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
337
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
337
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
911
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911